title: Analysis of correlations between patient-oriented SCORAD (PO-SCORAD) and other assessment scores of atopic dermatitis severity and quality of life.
abstract: OBJECTIVE
  Self-assessment scores such as the Patient-Oriented Scoring of Atopic Dermatitis (PO-SCORAD) index being recommended by public health authorities for chronic disease management, we aimed at analysing correlations between PO-SCORAD and physician and patient assessment scores of atopic dermatitis (AD) severity and quality of life.
  
  
  METHODS
  We perfomed an observational study conducted in 12 European countries in 4,222 atopic patients aged ≥1 month and prescribed Exomega® emollient cream. AD severity was measured by the SCORAD index, PO-SCORAD, Patient-Oriented Eczema Measure (POEM) and Self-Administered Eczema Area and Severity Index (SA-EASI) scales, and patient and family quality of life by the Dermatology Life Quality Index (DLQI) and Dermatitis Family Questionnaire Impact (DFQI) scales, respectively. Their correlations were analysed.
  
  
  RESULTS
  PO-SCORAD was the only self-assessment score to be highly correlated with the SCORAD index and POEM (r ≥ 0.70). It was also the best correlated with the DLQI (r = 0.67) and DFQI (r = 0.56). After a 5-week treatment, SCORAD index and PO-SCORAD severity scores had decreased significantly by 60 and 56% (p < 0.0001), and quality of life had improved.
  
  
  CONCLUSIONS
  PO-SCORAD is better correlated with quality of life scales than other self-assessment scores.
authors.affiliation: A-Derma Laboratories, Pierre Fabre Dermocosmétique, Lavaur, France.
authors.forename: Christine
authors.initials: C
authors.lastname: Coutanceau
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Stalder
mesh_terms: D000223:Adaptation, Psychological; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D002648:Child; D002675:Child, Preschool; D016001:Confidence Intervals; D003876:Dermatitis, Atopic / Q000175:diagnosis* / Q000188:drug therapy / Q000523:psychology*; D003879:Dermatologic Agents; D005060:Europe; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011788:Quality of Life; D018570:Risk Assessment; D012647:Self-Assessment; D012720:Severity of Illness Index; D012737:Sex Factors; D013315:Stress, Psychological; D011795:Surveys and Questionnaires; D055815:Young Adult
chemical_list: D003879:Dermatologic Agents